Friday, July 10, 2026

pharma · Advanced Solid Tumor · Chronic Lymphocytic Leukemia

BEONE MEDICINES AUS

BEONE MEDICINES AUS is a pharma organization headquartered in Cambridge, USA. Primary therapeutic focus areas include Advanced Solid Tumor, Chronic Lymphocytic Leukemia, Solid Tumor, Adult, Mantle Cell Lymphoma, Previous

Cambridge, USA HQ
2010 Founded
3,177 Employees
TGA registrant Type
Company details
Clinical program

BGB-11417

Phase 2 · small molecule · Acute Myeloid Leukemia

BGB-11417 for Acute Myeloid Leukemia is a Phase 2 program (small_molecule) at BEONE MEDICINES AUS PTY LTD with 1 ClinicalTrials.gov record(s).

Internal code BGB-11417-103

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
BEONE MEDICINES AUS PTY LTD
Phase
Phase 2
Modality
small_molecule
Indication
Acute Myeloid Leukemia
Status
active
Trials
1

Clinical trials